Section
Advanced Biologics
Peptides and other engineered biologic molecules, including antibodies, fusion proteins and engineered enzymes: how they are made, how they are tested, and where the human evidence stands.

Briefings

Advanced Biologics
A self injected peptide beat placebo on a daily tasks score in 174 adults
In a 12 week randomised trial in a disease that weakens muscles, the peptide group improved 2.09 points more than the placebo group on an eight item scale of everyday tasks. Approvals in three regions followed, and no trial has yet compared it against the other new treatments.
9 September 2026 · 6 min read · 4 sources

Advanced Biologics
An antibody carrying chemotherapy added five months in a 468 person trial
In advanced breast cancer of one type, median survival was 12.1 months against 6.7 months on the chemotherapy a doctor would otherwise have picked.
9 September 2026 · 6 min read · 3 sources

Advanced Biologics
No new HIV infections among 2,134 given a twice yearly injection
Two late stage randomised trials tested an injection given under the skin every 26 weeks against daily tablets.
9 September 2026 · 6 min read · 3 sources

Advanced Biologics
A swallowed peptide cut one kind of cholesterol 57.1 percent in a trial
The chain was joined into a ring so it could survive the gut, and 2,909 adults took it or an inactive tablet daily for 52 weeks.
8 September 2026 · 5 min read · 4 sources

Advanced Biologics
A review found 20 studies of a copper peptide, only two of them in people
The review searched three databases through March 2026.
8 September 2026 · 6 min read · 5 sources
From the reference
Browse all entriesNewsletter
The MetaResearch briefing
A short email when a study worth reading is published, with the finding, its limits and the link to the source.